{"id":"NCT03050307","sponsor":"Takeda","briefTitle":"Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection","officialTitle":"A Randomized Double-Blind, Double-Dummy, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-438 20mg Compared to Lansoprazole 30mg Once- or Twice-Daily in the Treatment of Endoscopically Confirmed Gastric Ulcer Subjects With or Without Helicobacter Pylori Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-04-17","primaryCompletion":"2020-02-19","completion":"2020-05-26","firstPosted":"2017-02-10","resultsPosted":"2021-06-18","lastUpdate":"2021-06-18"},"enrollment":234,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Gastric Ulcer"],"interventions":[{"type":"DRUG","name":"TAK-438","otherNames":["Vonoprazan"]},{"type":"DRUG","name":"Lansoprazole","otherNames":["Prevacid"]},{"type":"DRUG","name":"TAK-438 Placebo","otherNames":[]},{"type":"DRUG","name":"Lansoprazole Placebo","otherNames":[]},{"type":"DRUG","name":"Bismuth-Containing Quadruple Therapy","otherNames":[]}],"arms":[{"label":"TAK-438 20 mg","type":"EXPERIMENTAL"},{"label":"Lansoprazole 30 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to demonstrate the non-inferior efficacy of TAK-438 versus lansoprazole in the treatment of participants with gastric ulcer.","primaryOutcome":{"measure":"Percentage of Participants With Endoscopically Confirmed Healing of Gastric Ulcers (GUs) at Weeks 4 or 8","timeFrame":"Week 4 or 8","effectByArm":[{"arm":"TAK-438 20 mg","deltaMin":91.1,"sd":null},{"arm":"Lansoprazole 30 mg","deltaMin":94.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":81,"countries":["China","Philippines","South Korea","Taiwan"]},"refs":{"pmids":["39085080"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":115},"commonTop":["Pepsinogen test positive","Pepsinogen I increased","Blood gastrin increased","Alanine aminotransferase increased","Dysgeusia"]}}